The use of pulmonary clearance medications in the acutely ill patient

Michael F. Papacostas, Peter Luckett, Susan Hupp

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations


Introduction: Retention of airway secretions occurs in disease, leading to airway plugging, atelectasis, and worsened respiratory mechanics, making airway clearance an important therapeutic target. Areas covered: Many medications designed to enhance clearance of airway secretions are available. We will review the medications available to enhance airway clearance, their mechanisms of action, and the evidence available for their use in acutely ill patients. Expert commentary: In the cystic fibrosis (CF) population, beneficial effects have been shown in pulmonary function with the use of some of these agents. In the non-CF population, there is limited evidence regarding these medications. While some studies have found benefit, the quality of evidence is low, making it difficult to draw conclusions. While certain patients may derive benefit, the general use of these medications in acutely ill patients without CF cannot be recommended at this time.

Original languageEnglish (US)
Pages (from-to)815-826
Number of pages12
JournalExpert Review of Respiratory Medicine
Issue number10
StatePublished - Oct 3 2017


  • Airway secretions
  • hypertonic saline
  • mucolytics
  • mucus
  • pulmonary clearance
  • sputum

ASJC Scopus subject areas

  • Immunology and Allergy
  • Pulmonary and Respiratory Medicine
  • Public Health, Environmental and Occupational Health


Dive into the research topics of 'The use of pulmonary clearance medications in the acutely ill patient'. Together they form a unique fingerprint.

Cite this